---

---

sector : Commercial services    tags : Vaccine   

save search

---

Infant and Childhood Vaccine Schedule: What Parents Need to Know
Published: 2023-10-19 (Crawled : 21:00) - progyny.com
PGNY | $32.68 2.51% 2.45% 1.1M |

Commercial Services

| 2.44% | O: 0.22% H: 0.0% C: -1.15%
vaccine parents

---

Peer-Reviewed Journal Validates linearDNA™ as DNA-Based Vaccine
Published: 2023-01-05 (Crawled : 16:00) - adnas.com
APDN | $0.3396 0.59% 0.59% 85K |

Commercial Services

| -78.75% | O: -1.23% H: 20.31% C: 3.12%
vaccine

---

The Vitamin Shoppe Launches "Snax for Vax" Campaign with Free Giveaway of Healthy Snacks to Anyone Receiving a Flu Vaccine this Season
Published: 2022-10-12 (Crawled : 13:20) - prnewswire.com
FRG | $29.88 0.1% 0.1% 0 |

Commercial Services

| 14.82% | O: -0.12% H: 1.88% C: 0.62%
shoppe free vaccine

---

BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services
Published: 2022-10-03 (Crawled : 14:20) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K |

Commercial Services

| 18.06% | O: 0.55% H: 4.48% C: 2.98%
global services collaboration vaccine

---

Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
Published: 2022-09-30 (Crawled : 14:00) - adnas.com
APDN | $0.3396 0.59% 0.59% 85K |

Commercial Services

| -71.78% | O: -0.82% H: 11.56% C: -6.61%
candidate vaccine virus trial

---

Applied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets
Published: 2022-09-30 (Crawled : 13:20) - adnas.com
APDN | $0.3396 0.59% 0.59% 85K |

Commercial Services

| -71.78% | O: -0.82% H: 11.56% C: -6.61%
candidate vaccine virus trial

---

Applied DNA Biotherapeutics Subsidiary LineaRx and EvviVax Publish Additional Positive Animal Proof-of-Concept Data Supporting LinearDNA™ Platform as a Unique Approach to Veterinary DNA Vaccine Development
Published: 2022-07-25 (Crawled : 13:00) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K |

Commercial Services

| -54.7% | O: 1.32% H: 0.0% C: -11.42%
veterinary vaccine dna unique animal positive platform

---

Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
Published: 2022-06-23 (Crawled : 13:00) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K |

Commercial Services

| 10.73% | O: 0.09% H: 5.94% C: 5.04%
vaccine

---

Global Roundup: Clover's COVID-19 Vaccine Booster Reaches Phase III
Published: 2022-06-16 (Crawled : 13:20) - biospace.com/
CNTG | $0.463 0.43% 0.43% 79K |

Commercial Services

| -79.74% | O: -6.54% H: 5.64% C: 5.64%
covid-19 vaccine covid

---

Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
Published: 2022-06-07 (Crawled : 12:00) - adnas.com
APDN | $0.3396 0.59% 0.59% 85K |

Commercial Services

| -73.92% | O: -6.09% H: 3.26% C: -11.26%
preclinical vaccine positive cancer pre-clinical

---

GeoVax Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials
Published: 2022-03-14 (Crawled : 13:30) - biospace.com/
RSSS 4 | $3.02 -1.95% -1.99% 25K |

Commercial Services

| 42.33% | O: 1.07% H: 1.71% C: 1.25%
GOVX | $1.59 4.61% 4.4% 19K |

Health Technology

| 2.7% | O: 0.0% H: 1.35% C: -4.73%
covid-19 phase 2 als trials trial covid clinical trials vaccine

---

Insights on the Travel Vaccines Global Market to 2027 - by Composition, Disease and Region
Published: 2022-03-01 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -12.38% | O: -1.09% H: 0.05% C: 0.05%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 10.91% | O: 0.37% H: 2.02% C: 2.02%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 8.13% | O: 1.39% H: 0.0% C: 0.0%
ARVL | News | $0.49 0.37% 2.5M |

Manufacturing

| -83.82% | O: 5.88% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 5.6% | O: -1.55% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -11.3% | O: 0.64% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.5% | O: -1.34% H: 2.05% C: 1.47%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -11.49% | O: -1.96% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 9.64% | O: -0.62% H: 0.0% C: 0.0%
ALT | $6.91 0.29% 0.29% 3.6M |

Commercial Services

| -5.49% | O: 2.74% H: 1.34% C: -2.14%
travel disease vaccine

---

COVID-19 Update: FDA Vaccine Approval, Booster Shots, and Trying to Conceive
Published: 2021-11-01 (Crawled : 18:00) - progyny.com
PGNY | $32.68 2.51% 2.45% 1.1M |

Commercial Services

| -46.69% | O: 0.28% H: 2.64% C: 0.65%
covid fda vaccine approval covid-19

---

COVID-19 Update Webinar: FDA Vaccine Approval, Booster Shots, and Trying to Conceive
Published: 2021-11-01 (Crawled : 13:00) - progyny.com
PGNY | $32.68 2.51% 2.45% 1.1M |

Commercial Services

| -46.69% | O: 0.28% H: 2.64% C: 0.65%
covid fda vaccine approval covid-19

---

DLH Wins FEMA Contract for COVID-19 Vaccination and Testing Services Throughout Alaska
Published: 2021-10-14 (Crawled : 12:15) - globenewswire.com
DLHC | $11.26 1.99% 1.95% 32K |

Commercial Services

| -15.46% | O: 0.37% H: 6.67% C: 3.85%
covid test contract vaccine covid-19

---

Usio Wins Contract to Provide Prepaid Payments Infrastructure in Support of Houston’s COVID-19 Vaccine Incentive Program
Published: 2021-10-11 (Crawled : 14:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.1% | O: -0.23% H: 0.62% C: -0.38%
USIO 4 | $1.52 -0.65% -0.66% 1.1K |

Commercial Services

| -74.79% | O: 1.0% H: 0.0% C: -2.64%
covid contract vaccine

---

TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
Published: 2021-10-04 (Crawled : 13:00) - globenewswire.com
MRVI F | $7.3 -4.07% -4.25% 1.3M |

Commercial Services

| -83.29% | O: -7.94% H: 4.99% C: 0.43%
covid partnership eye biotech vaccine iot covid-19

---

Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease
Published: 2021-10-02 (Crawled : 00:20) - globenewswire.com
ADPT | $2.41 3.21% 3.11% 2.3M |

Commercial Services

| Email alert Add to watchlist
disease biotech vaccine iot injection sars-cov-2 infections

---

Progyny Webinar: COVID-19 Update: FDA Vaccine Approval, Booster Shots, and Trying to Conceive
Published: 2021-09-27 (Crawled : 15:00) - progyny.com
PGNY | $32.68 2.51% 2.45% 1.1M |

Commercial Services

| -48.37% | O: 0.46% H: 0.0% C: -4.35%
covid fda vaccine approval covid-19

---

U.S. Rapid Action Consortium Commends President Biden's Call for Vaccines, Testing
Published: 2021-09-10 (Crawled : 16:00) - prnewswire.com
G | $31.59 2.27% 0.0% 1.3M |

Commercial Services

| -40.24% | O: 0.57% H: 0.27% C: -2.65%
test vaccine

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---